From Cancer to Neuroprotection: Pazopanib Modulates the RIPK1/RIPK3/MLKL and PGAM5/DRP1 Pathways in 3- Nitropropionic Acid-Induced Huntington's Disease.
Saved in:
| Title: | From Cancer to Neuroprotection: Pazopanib Modulates the RIPK1/RIPK3/MLKL and PGAM5/DRP1 Pathways in 3- Nitropropionic Acid-Induced Huntington's Disease. |
|---|---|
| Authors: | Eltarzy MA; Department of Pharmacology and Toxicology, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology (MUST), Giza, Egypt., Rabie MA; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Giza, Egypt., Sayed RH; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Giza, Egypt.; Department of Clinical Pharmacy, School of Pharmacy, Newgiza University, Giza, Egypt., Ahmed MAE; Department of Pharmacology and Toxicology, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology (MUST), Giza, Egypt., Ahmedy OA; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Giza, Egypt. |
| Source: | Drug development research [Drug Dev Res] 2026 Apr; Vol. 87 (2), pp. e70238. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8204468 Publication Model: Print Cited Medium: Internet ISSN: 1098-2299 (Electronic) Linking ISSN: 02724391 NLM ISO Abbreviation: Drug Dev Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1098-2299 |
|---|---|
| DOI: | 10.1002/ddr.70238 |
